89
Participants
Start Date
November 23, 2015
Primary Completion Date
January 23, 2017
Study Completion Date
April 13, 2017
Erenumab
A single dose of erenumab 140 mg infused over approximately 60 minutes.
Placebo
A single dose of a matching volume of placebo infused over approximately 60 minutes.
Research Site, Grafton, Auckland
Research Site, Riga
Research Site, Geneva
Research Site, Sofia
Research Site, Sofia
Research Site, Sofia
Research Site, Haskovo
Research Site, Parow
Research Site, Christchurch
Research Site, Atlanta
Research Site, Jacksonville
Research Site, Miami
Research Site, Jackson
Research Site, Chicago
Research Site, Wichita Falls
Research Site, New Braunfels
Research Site, Las Vegas
Research Site, Timișoara
Research Site, Brandýs nad Labem
Research Site, Chomutov
Research Site, Prague
Research Site, Pribram VIII
Research Site, Krakow
Research Site, Lodz
Research Site, Zabrze
Research Site, Bardejov
Research Site, Brezno
Research Site, Lučenec
Research Site, Piešťany
Research Site, Prešov
Research Site, Svidník
Research Site, Trenčín
Research Site, Žilina
Lead Sponsor
Amgen
INDUSTRY